SCHEMBL25812184

SCHEMBL25812184

CNC(=O)c1cc2ccc(C)c(F)c2[nH]1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.50
EIF4A3 P38919 1/20 0.48
NSD2 O96028 2/20 0.46
PTPN11 Q06124 1/20 0.43
HDAC3 O15379 1/20 0.42
HDAC4 P56524 1/20 0.42
HDAC1 Q13547 1/20 0.42
HDAC7 Q8WUI4 1/20 0.42
HDAC2 Q92769 1/20 0.42
HDAC10 Q969S8 1/20 0.42
HDAC11 Q96DB2 1/20 0.42
HDAC8 Q9BY41 1/20 0.42
HDAC6 Q9UBN7 1/20 0.42
HDAC9 Q9UKV0 1/20 0.42
HDAC5 Q9UQL6 1/20 0.42
NPC1 O15118 5/20 0.41
RAB9A P51151 5/20 0.41
RXFP1 Q9HBX9 3/20 0.41
POLB P06746 2/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27523308 0.82 EIF4A3 (0.68) EIF4A3NSD2MEN1KMT2AMAPT
SCHEMBL30147532 0.78 HRH4 (0.59) ALOX15NSD2PTPN11HDAC3HDAC1
SCHEMBL21739280 0.78 HRH4 (0.56) NSD2HRH4SETD2
SCHEMBL21235399 0.77 ALOX15 (0.49) ALOX15EIF4A3PTPN11NPC1RAB9A
SCHEMBL5356682 0.76 CDK1 (0.55) ALOX15EIF4A3NPC1RAB9APOLB
SCHEMBL24740292 0.75 ALOX15 (0.57) ALOX15NSD2PTPN11NPC1POLB
SCHEMBL24113538 0.74 HRH4 (0.54) ALOX15PTPN11NPC1RAB9ARXFP1
SCHEMBL30147583 0.73 ALOX15 (0.68) ALOX15NPC1RAB9ARXFP1KDM4E
SCHEMBL30471285 0.72 IDO1 (0.54) ALOX15NSD2PTPN11KMT2AHRH4
SCHEMBL15146698 0.72 PTPN11 (0.57) ALOX15NSD2PTPN11HDAC3HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF Pardes Biosciences, Inc. 2023-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230212152-A1 INHIBITORS OF CYSTEINE PROTEASES AND METHODS OF USE THEREOF CTRL, CTSL, CTSV ALOX15 1455/4885EIF4A3 582/4885NSD2 2375/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.